NCT01695005 2025-12-26A Study of LY3039478 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed247 enrolled 53 charts
NCT02784795 2025-08-21A Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsEli Lilly and CompanyPhase 1 Terminated94 enrolled 28 charts
NCT02518113 2019-09-11A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBLEli Lilly and CompanyPhase 1/2 Completed36 enrolled 17 charts